NCT04385017View on ClinicalTrials.gov

Role of Inflammasomes in COVID-19 Disease

NACompletedINTERVENTIONAL
Enrollment

99

Participants

Timeline

Start Date

May 11, 2020

Primary Completion Date

February 1, 2022

Study Completion Date

December 30, 2022

Conditions
COVID-19 by SARS-CoV-2 Infection
Interventions
OTHER

COVID-19 patients

It will consist in the collection of 2 additional tubes at their blood draw. For DNA analysis, informed consent will be collected in writing

Trial Locations (2)

06

Ch Cannes, Réanimation, Cannes

06200

CHU de nice, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT04385017 - Role of Inflammasomes in COVID-19 Disease | Biotech Hunter | Biotech Hunter